ERBB2 and breast carcinoma: A study on the effects of a combined treatment with 5-fluorouracil (5-FU) and apigenin has shown cell growth inhibition and apoptosis induction via the downregulation of ErbB2 expression and Akt signaling in human breast cancer cells [49].